Know Cancer

or
forgot password

Changes of T-cell-immune-status During Curative Radiotherapy in Prostate Cancer


N/A
18 Years
90 Years
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

Changes of T-cell-immune-status During Curative Radiotherapy in Prostate Cancer


Inclusion Criteria:



- Localised prostate cancer (node negative)

- definitive radiotherapy

- informed consent

Exclusion Criteria:

- medication including steroids or immunosuppressants

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

T-cell-immunity in time-course

Outcome Time Frame:

During and 3-6 months after radiotherapy

Safety Issue:

No

Principal Investigator

Cihan Gani, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital Tuebingen

Authority:

Germany: Federal Institute for Drugs and Medical Devices

Study ID:

UKT_RO_01

NCT ID:

NCT01376674

Start Date:

March 2011

Completion Date:

Related Keywords:

  • Prostate Cancer
  • localised
  • prostate cancer
  • radiotherapy
  • immunology
  • Prostatic Neoplasms

Name

Location